CLPBF
Price
$111.33
Change
+$5.50 (+5.20%)
Updated
Jan 17 closing price
Capitalization
26.46B
CLPBY
Price
$11.14
Change
+$0.09 (+0.81%)
Updated
Jan 17 closing price
Capitalization
26.46B
16 days until earnings call
Ad is loading...

CLPBF vs CLPBY

Header iconCLPBF vs CLPBY Comparison
Open Charts CLPBF vs CLPBYBanner chart's image
Coloplast AS
Price$111.33
Change+$5.50 (+5.20%)
Volume$3
Capitalization26.46B
Coloplast AS
Price$11.14
Change+$0.09 (+0.81%)
Volume$184.81K
Capitalization26.46B
CLPBF vs CLPBY Comparison Chart
Loading...
CLPBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLPBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPBF vs. CLPBY commentary
Jan 19, 2025

To understand the difference between Coloplast AS - Ordinary Shares - Class B (CLPBF) vs. Coloplast AS - ADR (CLPBY) it is enough to know the definitions of Ordinary Shares - Class B and ADR

Ordinary Shares - Class B - Generally, Class B shares are issued by a company as a common stock with fewer voting rights and lower dividend priority than Class A shares. Class B may also have lower repayment priority in the event of a bankruptcy.

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CLPBF: $111.32 vs. CLPBY: $11.14)
Brand notoriety: CLPBF and CLPBY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CLPBF: 1% vs. CLPBY: 93%
Market capitalization -- CLPBF: $26.46B vs. CLPBY: $26.46B
CLPBF [@Medical Specialties] is valued at $26.46B. CLPBY’s [@Medical Specialties] market capitalization is $26.46B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPBF’s FA Score shows that 1 FA rating(s) are green whileCLPBY’s FA Score has 1 green FA rating(s).

  • CLPBF’s FA Score: 1 green, 4 red.
  • CLPBY’s FA Score: 1 green, 4 red.
According to our system of comparison, CLPBY is a better buy in the long-term than CLPBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPBF’s TA Score shows that 1 TA indicator(s) are bullish while CLPBY’s TA Score has 4 bullish TA indicator(s).

  • CLPBF’s TA Score: 1 bullish, 2 bearish.
  • CLPBY’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, CLPBY is a better buy in the short-term than CLPBF.

Price Growth

CLPBF (@Medical Specialties) experienced а +5.20% price change this week, while CLPBY (@Medical Specialties) price change was +1.64% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

CLPBY is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLPBF($26.5B) and CLPBY($26.5B) have the same market capitalization . CLPBF (36.76) and CLPBY (36.50) have similar P/E ratio . CLPBF YTD gains are higher at: 2.811 vs. CLPBY (2.578). CLPBF (7.65B) and CLPBY (7.65B) have comparable annual earnings (EBITDA) . CLPBF (24.1B) and CLPBY (24.1B) have equivalent revenues.
CLPBFCLPBYCLPBF / CLPBY
Capitalization26.5B26.5B100%
EBITDA7.65B7.65B100%
Gain YTD2.8112.578109%
P/E Ratio36.7636.50101%
Revenue24.1B24.1B100%
Total Cash881MN/A-
Total Debt22.2BN/A-
FUNDAMENTALS RATINGS
CLPBF vs CLPBY: Fundamental Ratings
CLPBF
CLPBY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
7
Undervalued
PROFIT vs RISK RATING
1..100
10097
SMR RATING
1..100
3434
PRICE GROWTH RATING
1..100
7459
P/E GROWTH RATING
1..100
7474
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPBF's Valuation (6) in the null industry is in the same range as CLPBY (7). This means that CLPBF’s stock grew similarly to CLPBY’s over the last 12 months.

CLPBY's Profit vs Risk Rating (97) in the null industry is in the same range as CLPBF (100). This means that CLPBY’s stock grew similarly to CLPBF’s over the last 12 months.

CLPBY's SMR Rating (34) in the null industry is in the same range as CLPBF (34). This means that CLPBY’s stock grew similarly to CLPBF’s over the last 12 months.

CLPBY's Price Growth Rating (59) in the null industry is in the same range as CLPBF (74). This means that CLPBY’s stock grew similarly to CLPBF’s over the last 12 months.

CLPBY's P/E Growth Rating (74) in the null industry is in the same range as CLPBF (74). This means that CLPBY’s stock grew similarly to CLPBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPBFCLPBY
RSI
ODDS (%)
N/A
Bullish Trend 12 days ago
52%
Stochastic
ODDS (%)
N/A
Bullish Trend 12 days ago
66%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
52%
Bullish Trend 12 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
53%
Bearish Trend 12 days ago
57%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
67%
Declines
ODDS (%)
Bearish Trend 18 days ago
55%
Bearish Trend 18 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
55%
N/A
Aroon
ODDS (%)
Bearish Trend 12 days ago
54%
Bearish Trend 12 days ago
69%
View a ticker or compare two or three
Ad is loading...
CLPBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLPBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISIVX19.410.19
+0.99%
Voya US Stock Index Port A
GCMTX35.790.26
+0.73%
Goldman Sachs Mid Cap Value Inv
RAMHX34.810.22
+0.64%
American Funds American Balanced R2E
MGLSX9.010.04
+0.45%
Mercer Global Low Volatility Equity I
EUGDX26.41-0.01
-0.04%
Morgan Stanley Europe Opportunity I

CLPBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPBF has been loosely correlated with CLPBY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBF jumps, then CLPBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBF
1D Price
Change %
CLPBF100%
+5.20%
CLPBY - CLPBF
38%
Loosely correlated
+0.81%
AHICF - CLPBF
26%
Poorly correlated
N/A
WILLF - CLPBF
22%
Poorly correlated
N/A
QDEL - CLPBF
20%
Poorly correlated
-0.33%
ESLOY - CLPBF
20%
Poorly correlated
+2.21%
More

CLPBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPBY has been loosely correlated with CLPBF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBY jumps, then CLPBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBY
1D Price
Change %
CLPBY100%
+0.81%
CLPBF - CLPBY
38%
Loosely correlated
+5.20%
SAUHY - CLPBY
34%
Loosely correlated
+1.11%
SMMNY - CLPBY
33%
Poorly correlated
+1.75%
SONVY - CLPBY
32%
Poorly correlated
-0.72%
ESLOY - CLPBY
32%
Poorly correlated
+2.21%
More